Anti-SSA/Ro autoantibodies

Anti-SSA autoantibodies (also called anti-Ro, or the combination anti-SSA/Ro or anti Ro/SSA autoantibodies) are anti-nuclear autoantibodies that are associated with among many autoimmune diseases, such as systemic lupus erythematosus (SLE), SS/SLE overlap syndrome, subacute cutaneous LE (SCLE), neonatal lupus and primary biliary cirrhosis.[1] Also, they are often present in Sjögren's syndrome.[2] [3]

Presence of Anti-SSA/Ro in pregnant women with SLE is associated with an increased risk of neonatal lupus erythematosus in the child.[4]

Approximately only 0.1 to 0.5 percent of the general population has the antibody.

References

  1. ^ Franceschini, F.; Cavazzana, I. (2005). "Anti-Ro/SSA and La/SSB antibodies". Autoimmunity 38 (1): 55–63. doi:10.1080/08916930400022954. PMID 15804706.  edit
  2. ^ Franceschini F, Cavazzana I (February 2005). "Anti-Ro/SSA and La/SSB antibodies". Autoimmunity 38 (1): 55–63. doi:10.1080/08916930400022954. PMID 15804706. 
  3. ^ V Goëb et al. (2007). "Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome". Clin. Exp. Immunol. 148 (2): 281–7. doi:10.1111/j.1365-2249.2007.03337.x. PMC 1868868. PMID 17286756. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1868868. 
  4. ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. Page 160. ISBN 0-7216-2921-0.